Nonalcoholic fatty liver disease is associated with coronary artery disease and subclinical atherosclerosis

Future Cardiology

Volumn 12, Issue 4, 2016, Pages 393-396

  Aronow, Wilbert S ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

atherosclerotic cardiovascular disease; brachial ankle pulse wave velocity; cardioankle vascular index; carotid intima media thickness; coronary artery calcification; coronary artery disease; nonalcoholic fatty liver disease

Indexed keywords

ARTERIAL WALL THICKNESS; ATHEROSCLEROSIS; CAUSAL ATTRIBUTION; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; HUMAN; INSULIN RESISTANCE; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; REVIEW; SUBCLINICAL ATHEROSCLEROSIS; SURVIVAL RATE; COMPLICATION;

ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; HUMANS; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84975691167     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca-2016-0033     Document Type: Review

References (20)

1. Milić S, Lulić D, Štimac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J. Gastroenterol. 20(28), 9330-9337 (2014).
2. Wong VW, Wong GL, Yip GW et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 60(12), 1721-1727 (2011).
3. Targher G, Bertolini L, Rodella S et al. Nonalcoholic liver disease and risk of future cardiovascular events among Type 2 diabetic patients. Diabetes 54(12), 3541-3546 (2005).
4. Hamaguchi M, Kojima T, Takeda N et al. Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J. Gastroenterol. 13(10), 1579-1584 (2007).
5. Pisto P, Santaniemi M, Bloigu R et al. Fatty liver predicts the risk for cardiovascular events in middle-aged population: A populationbased cohort study. BMJ Open 4(3), e004973 (2014).
6. Idilman IS, Akata D, Hazirolan T et al. Nonalcoholic fatty liver disease is associated with significant coronary artery disease in Type 2 diabetic patients: A computed tomography angiography study 2. J. Diabetes 7(2), 279-286 (2015).
7. Alper AT, Hasdemir H, Sahin S et al. The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome. Turk. Kardiyol. Dern. Ars. 36(6), 376-381 (2008).
8. Açikel M, Sunay S, Koplay M et al. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography. Anadolu. Kardiyol. Derg. 9(4), 273-279 (2009).
9. Sun L, Lü SZ. Association between non-alcoholic fatty liver disease and coronary artery disease severity. Chin. Med. J. (Engl.). 124(6), 867-872 (2011).
10. Arslan U, Kocaoǧlu I, Balci M et al. The association between impaired collateral circulation and non-alcoholic fatty liver in patients with severe coronary artery disease. J. Cardiol. 60(3), 210-214 (2012).
11. Sung KC, Wild SH, Kwag HJ, Byrne CD. Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people. Diabetes Care 35(11), 2359-2364 (2012).
12. VanWagner LB, Ning H, Lewis CE et al. Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The Coronary Artery Risk Development in Young Adults Study. Atherosclerosis 235(2), 599-605 (2014).
13. Al Rifai M, Silverman MG, Nasir K et al. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis 239(2), 629-633 (2015).
14. Thakur ML, Sharma S, Kumar A et al. Nonalcoholicfatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians. Atherosclerosis 223(2), 507-511 (2012).
15. Huang Y, Bi Y, Xu M et al. Nonalcoholic fatty liver disease is associated with atherosclerosis in middle-aged and elderly Chinese. Arterioscler. Thromb. Vasc. Biol. 32(9), 2321-2326 (2012).
16. Ampuero J, Gallego-Durán R, Romero-Gómez M. Association of NAFLD with subclinical atherosclerosis and coronary-artery disease: meta-analysis. Rev. Esp. Enferm. Dig. 107(1), 10-16 (2015).
17. Li N, Zhang GW, Zhang JR et al. Non-alcoholic fatty liver disease is associated with progression of arterial stiffness. Nutr. Metab. Cardiovasc. Dis. 25(2), 218-223 (2015).
18. Izuhara M, Shioji K, Kadota S et al. Relationship of cardio-ankle vascular index (CAVI) to carotid and coronary arteriosclerosis. Circ. J. 72(11), 1762-1767 (2008).
19. Suzuki J, Sakakibara R, Tomaru T et al. Stroke and cardio-ankle vascular stiffness index. J. Stroke Cerebrovasc. Dis. 22(2), 171-175 (2013).
20. Chung GE, Choi SY, Kim D et al. Nonalcoholic fatty liver disease as a risk factor of arterial stiffness measured by the cardioankle vascular index. Medicine (Baltimore) 94(12), e654 (2015).